Aerovate Therapeutics Inc Ownership
$15.04
3.23%
Nasdaq, Wed, Nov 04 2026.
Aerovate Therapeutics Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Fidelity Management & Research Company LLC
|
8.868m | 13.95% | +1.915m | Jun 30 2026 |
| 2 |
Janus Henderson Investors
|
6.273m | 9.87% | +3.168m | Jun 30 2026 |
| 3 |
Fairmount Funds Management LLC
|
4.553m | 7.16% | — | Jun 30 2026 |
| 4 |
RA Capital Management, LP
|
3.671m | 5.78% | — | Jun 30 2026 |
| 5 |
VR Adviser, LLC
|
3.220m | 5.07% | — | Jun 30 2026 |
|
1
Fidelity Management & Research Company LLC
|
13.95%
8.868m
|
|
2
Janus Henderson Investors
|
9.87%
6.273m
|
|
3
Fairmount Funds Management LLC
|
7.16%
4.553m
|
|
4
RA Capital Management, LP
|
5.78%
3.671m
|
|
5
VR Adviser, LLC
|
5.07%
3.220m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 41.83% of Aerovate Therapeutics Inc, with Fidelity Management & Research Company LLC the biggest at 13.95%, followed by Janus Henderson Investors (9.87%) and Fairmount Funds Management LLC (7.16%). |
Recent Aerovate Therapeutics Inc Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Nov 05 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Nov 02 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 29 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Oct 24 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Oct 18 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Oct 11 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Nov 05 2026
$182.45
|
|
Sarah Chen
SALES
|
Nov 02 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 29 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Oct 24 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Oct 18 2026
$170.50
|
|
Lisa Park
SALES
|
Oct 11 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
